Navigation Links
PacificGMP Completes GMP Product Fill for Trius Therapeutics
Date:5/14/2008

SAN DIEGO, May 14 /PRNewswire/ -- PacificGMP, the leader in utilizing single-use bioprocessing for development and manufacturing for its client partners, announced today that it has completed a product fill under GMP (good manufacturing practices) standards for a Trius Therapeutics Phase I clinical trial.

"We are pleased to have worked closely with Trius on this GMP fill project, an effort that we were able to initiate quickly and complete within a narrow deadline," said Leigh N. Pierce, president of PacificGMP. "Although our client base consists of mainly biologics drug developers, PacificGMP has completed projects for a variety of other customers including small molecule drug developers like Trius, as well as academic institutions and diagnostics companies."

"PacificGMP successfully completed our GMP product fill and I appreciated their flexibility and willingness to work with us to get the job done in a timely and professional manner," said Jeffrey Barker, Director of Pharmaceutical Development for Trius Therapeutics.

About PacificGMP

PacificGMP is a contract manufacturing organization (CMO) and industry leader in utilizing single-use bioprocessing for development and manufacturing of biologics. Single-use technology eliminates the risk of cross-contamination, has fewer system requirements and significantly reduces the time required to initiate production. Benefits to clients include rapid project turnaround and the most cost effective solution in the industry. PacificGMP provides cGMP and non-GMP services ranging from cell line optimization, early process design, development and scale-up, to preclinical and clinical biologics manufacturing, purification and fill/finish. More information can be found by visiting the Company's web site at http://www.pacificGMP.com.

About Trius Therapeutics

Trius Therapeutics is discovering and developing innovative antibacterial
'/>"/>

SOURCE PacificGMP
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
6. QuatRx Completes Patient Enrollment in Phase 3 Study of Ophena(TM) in Women with Postmenopausal Vaginal Syndrome
7. CryoCor Completes Enrollment of Pivotal Clinical Study for Atrial Fibrillation
8. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
9. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
10. Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
11. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... Aug. 1, 2014 In the latest call ... sexual dysfunction, more than 60 doctors and leading medical ... letter questioning the Food and Drug Administration,s (FDA) decision ... form of male sexual dysfunction compared with ZERO for ... to act for women by approving the first-ever drug ...
(Date:8/1/2014)... , Aug. 1, 2014 RoundTable Healthcare ... exclusively on the healthcare industry, announced today the ... Lubrizol Corporation ("Lubrizol"). Lubrizol, a Berkshire Hathaway company, ... supplies technologies to customers in the global transportation, ... were not disclosed. Vesta is an ...
(Date:8/1/2014)... , Aug. 1, 2014 Aspire Technology Partners (Aspire) ... Gold Star from Cisco. This designation recognizes Aspire for delivering ... States of America . "Achieving exceptional results ... John C. Harris , President and CEO of Aspire. "We ... with their Gold Star award and are proud to be ...
Breaking Medicine Technology:60+ Doctors and Leading Medical Experts Sign an Open Letter Urging the FDA to Approve First-Ever Drug to Treat Women's Most Common Form of Sexual Dysfunction, notes Even the Score 260+ Doctors and Leading Medical Experts Sign an Open Letter Urging the FDA to Approve First-Ever Drug to Treat Women's Most Common Form of Sexual Dysfunction, notes Even the Score 3RoundTable Healthcare Partners Announces Sale of Vesta Funding, Inc. to The Lubrizol Corporation 2Aspire Technology Partners Recognized By Cisco For Excellence In Customer Satisfaction 2
... Aug. 1, 2011 Reportlinker.com announces that ... in its catalogue: Insulin- ... This package contains 14 ... European countries: Austria, Belgium, Denmark, Finland, France, ...
... Aug. 1, 2011 Reportlinker.com announces that ... in its catalogue: Vaccines ... http://www.reportlinker.com/p0578257/Vaccines---Eastern-Europe.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This package contains ... Eastern European countries: Bulgaria, Czech Republic, Estonia, ...
Cached Medicine Technology:Insulin- Western Europe 2Vaccines - Eastern Europe 2
(Date:8/1/2014)... 2014 According to new market ... (Asia-Pacific, North America, Europe, & ROW), by Vehicle ... Type (Gasoline & Diesel), by After-Treatment Device (DPF, ... & Forecasts to 2019", defines and segments the ... of major countries in all the regions, and ...
(Date:8/1/2014)... (PRWEB) August 01, 2014 The North ... endpoint security solutions market in North America with analysis ... grow from around $3.53 billion in 2014 to $4.77 ... 2014 to 2019. , Browse through the TOC of ... an idea of the in-depth analysis provided. It also ...
(Date:8/1/2014)... 2014 For years, proponents have praised ... study conducted by the Ohio State University, ... behind in terms of their health and development, raising ... best for their baby. So does this new research ... Steven Shapiro , chair of Pediatrics at Abington Memorial ...
(Date:8/1/2014)... Over the past five years, ... technologies that have enabled cosmetic dentists to provide ... Moreover, the burgeoning elderly population has stimulated demand ... Due to long-term use of medications, which may ... dental fillings, veneers and implants. As more elderly ...
(Date:8/1/2014)... YORK, NY August 1, 2014 The ... trials and first report investigations that will be ... 2014 scientific symposium. TCT, the world,s premier educational ... place September 13 17, 2014 at the ... , Clinical research data presented at TCT often ...
Breaking Medicine News(10 mins):Health News:Automotive Exhaust Systems Market Will Be $33,379.7 Million by 2019 – New Report by MarketsandMarkets 2Health News:Automotive Exhaust Systems Market Will Be $33,379.7 Million by 2019 – New Report by MarketsandMarkets 3Health News:Automotive Exhaust Systems Market Will Be $33,379.7 Million by 2019 – New Report by MarketsandMarkets 4Health News:North America End-Point Security Market is Expected to Reach $4 billion in 2019 - New Report by MicroMarket Monitor 2Health News:North America End-Point Security Market is Expected to Reach $4 billion in 2019 - New Report by MicroMarket Monitor 3Health News:North America End-Point Security Market is Expected to Reach $4 billion in 2019 - New Report by MicroMarket Monitor 4Health News:Despite Recent Study, Abington Health Expert Encourages Breastfeeding 2Health News:Despite Recent Study, Abington Health Expert Encourages Breastfeeding 3Health News:Cosmetic Dentists in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Cosmetic Dentists in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:CRF announces late-breaking trials and first report investigations for TCT 2014 2Health News:CRF announces late-breaking trials and first report investigations for TCT 2014 3Health News:CRF announces late-breaking trials and first report investigations for TCT 2014 4
... and WINSTON-SALEM, N.C., March 27 Prince William ... Carolina-based Novant Health, both regional not-for-profit health systems, ... intent to merge. The partnership will provide ... to western Prince William County. "We chose to ...
... covers the entire spectrum - from medical imaging, ... March 27 /PRNewswire/ -- Siemens Healthcare ( ... commitment to excellence "From Prevention to Follow-up" at ... College of Cardiology (ACC), March 29-31 in Orlando, ...
... team of scientists at Emory University School of Medicine ... inflammatory signals in the blood. The finding could lead ... antioxidants in the diet and for reducing the impact ... to intravenous or tube feeding. , The results are ...
... Analysis shows most documents require reading skills beyond those ... -- This one should come as no surprise to ... that outlines your expectations for medical care, is usually ... that you need college-level reading skills to understand ...
... Beauty Show, March 28-30 in Chicago, is dedicated ... doing so, the Show raises serious and decades ... salons. Salon products are generally dispensed from bulk ... is the cumulative contamination of air, particularly in ...
... 27 Cord Blood America, Inc. (OTC Bulletin Board: ... ( http://www.cordblood-america.com ) focused on ... families nationwide and internationally, said today it strongly supports ... U.S. House of Representatives.The legislation will provide tax incentives ...
Cached Medicine News:Health News:Prince William Health System and Novant Health Agree on Partnership to Expand Quality Healthcare in Northern Virginia 2Health News:Prince William Health System and Novant Health Agree on Partnership to Expand Quality Healthcare in Northern Virginia 3Health News:Siemens Highlights Cardiology Excellence from Prevention to Follow-up at ACC 2009 2Health News:Siemens Highlights Cardiology Excellence from Prevention to Follow-up at ACC 2009 3Health News:Siemens Highlights Cardiology Excellence from Prevention to Follow-up at ACC 2009 4Health News:Siemens Highlights Cardiology Excellence from Prevention to Follow-up at ACC 2009 5Health News:Siemens Highlights Cardiology Excellence from Prevention to Follow-up at ACC 2009 6Health News:Siemens Highlights Cardiology Excellence from Prevention to Follow-up at ACC 2009 7Health News:Targeting oxidized cysteine through diet could reduce inflammation and lower disease risk 2Health News:Patients' Bill of Rights Too Tough to Read 2Health News:Patients' Bill of Rights Too Tough to Read 3Health News:America's Beauty Show Challenges Toxic Salons 2Health News:America's Beauty Show Challenges Toxic Salons 3Health News:Cord Blood America Applauds Congressional Effort Supporting Cord Blood Storage 2
CapSureSP Novus 5594 is a J-shaped, endocardial, tined pacing lead. provide the stable, low pacing thresholds and large sensing potentials already proven with CapSure SP steroid-eluting leads but wi...
The Guidant Fineline II Sterox Atrial J is a steroid-eluting pacing lead designed for permanent implantation for either atrial or ventricular applications....
The Guidant Fineline II Sterox is a steroid-eluting pacing lead designed for permanent implantation for either atrial or ventricular applications....
The electrically active helix of CapSureFix Novus lead is designed to extend easily for active fixation and retract for venous passage....
Medicine Products: